Since the beginning of the COVID-19 pandemic, the diagnosis and evaluation of these patients has been a challenge. The characteristics of the infection have forced us to adapt and thus ultrasound has emerged as a very useful tool in the evaluation of these patients. However, although lung ultrasound has been the most studied, nowadays we know that COVID presents a multiorgan involvement that influences management and prognosis. It is here where multiventana or multiorgan ultrasound is of great importance. Despite this, there is no protocol and it was not until August 2020 when experts from different countries met to analyze and collect for the first time the potentially useful applications of this technique and drew up a consensus document. These recommendations represent the starting point for the use of multiorgan ultrasound, not only lung ultrasound in COVID-19 patients.Therefore, the aim of this review is to evaluate the efficacy of the use of bedside ultrasound in the integral management of the COVID-19 patient and to analyze the current state of its use at all levels and to assess the new developments.